Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - SHORT-TERM DEBT
Short-term Debt INZY - Inozyme Pharma, Inc.
910 K
LAST VALUE
-21.11%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR